Shares of Tissue Regenix Group plc (LON:TRX – Get Free Report) hit a new 52-week low on Monday . The company traded as low as GBX 50.50 ($0.64) and last traded at GBX 52 ($0.65), with a volume of 219985 shares trading hands. The stock had previously closed at GBX 53.92 ($0.68).
Tissue Regenix Group Stock Down 9.8 %
The company has a debt-to-equity ratio of 31.16, a current ratio of 4.03 and a quick ratio of 2.36. The firm has a market cap of £42.37 million, a PE ratio of -48.52 and a beta of 1.61. The business has a fifty day moving average price of GBX 57.84 and a two-hundred day moving average price of GBX 58.58.
About Tissue Regenix Group
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Further Reading
- Five stocks we like better than Tissue Regenix Group
- Ride Out The Recession With These Dividend Kings
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- How to Invest in Small Cap Stocks
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Stock Dividend Cuts Happen Are You Ready?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
